A nurse is providing discharge teaching to a patient who will be taking levodopa/carbidopa for Parkinson's Disease (PD). Which of the following statements by the patient indicates a need for further teaching?

A. Ondansetron (Zofran) and metoclopramide (Reglan): These medications are used to treat nausea and vomiting, often related to gastrointestinal issues or as side effects of other treatments. They are not indicated for the treatment of Huntington's Disease (HD), which primarily involves movement and psychiatric symptoms.

B. Haloperidol (Haldol) and chlorpromazine (Thorazine): These are antipsychotic medications that can be used to treat the psychiatric symptoms of Huntington's Disease (such as agitation, psychosis, and chorea). However, they are older, first-generation antipsychotics and are associated with more severe side effects, such as extrapyramidal symptoms. While they can still be used, they are generally less favored due to these side effects.

C. Risperidone (Risperdal) and quetiapine (Seroquel): These are atypical antipsychotic medications, which are often preferred for managing psychiatric symptoms (e.g., psychosis, aggression, mood disturbances) in Huntington's Disease. These medications have a lower risk of extrapyramidal symptoms compared to first-generation antipsychotics, making them a better choice for patients in the later stages of HD.

D. Riluzole (Rilutek) and baclofen (Lioresal): Riluzole is used in amyotrophic lateral sclerosis (ALS), not Huntington's Disease. Baclofen is a muscle relaxant that can be used to manage spasticity, but it is not a primary treatment for HD. The focus for HD treatment would be more on managing movement disorders and psychiatric symptoms, rather than spasticity.

A. Increasing blood viscosity is not a goal in the care of a patient with acute myocardial infarction (MI). In fact, reducing blood viscosity by using anticoagulants or antiplatelets is typically part of the treatment to prevent clot formation.
B. Preventing complications, such as arrhythmias, heart failure, or recurrent infarction, is a key goal in the care of a patient after an acute MI.
C. Relieving chest pain is a priority goal in MI care, as it improves the patient's comfort and helps in reducing myocardial oxygen demand.
D. Increasing cardiac workload can worsen myocardial ischemia and damage. The goal is to reduce workload, not increase it, by using medications like beta-blockers and nitrates to decrease heart rate and blood pressure.
E.Reducing myocardial damage is essential, often achieved through interventions such as thrombolytic therapy, percutaneous coronary interventions (PCI), and medications to restore blood flow and limit infarction size.